Search

Search Constraints

You searched for: Author/Creator Rutgeerts, P

Search Results

3. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn's disease. Issue 8 (21st February 2006)